Cisplatin

proteasome 26S subunit, non-ATPase 1 ; Homo sapiens







53 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 28554183 A Pilot Trial of S-1 and Paclitaxel in Unresectable or Postoperative Recurrent Esophageal Squamous Cell Carcinoma Pretreated by Fluorouracil, Cisplatin, and Docetaxel Chemotherapy. 2018 2
2 29488122 A phase II trial of capecitabine plus cisplatin (XP) for patients with advanced gastric cancer with early relapse after S-1 adjuvant therapy: XParTS-I trial. 2018 Sep 1
3 27299887 A phase II study of preoperative chemotherapy with docetaxel, cisplatin, and S-1 followed by gastrectomy with D2 plus para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis: JCOG1002. 2017 Mar 1
4 27643822 New Perspectives in the Treatment of Advanced Gastric Cancer: S-1 as a Novel Oral 5-FU Therapy in Combination with Cisplatin. 2017 1
5 28101359 Effect of combined treatment with micelle-incorporated cisplatin (NC-6004) and S-1 on human gastric cancer xenografts. 2016 Dec 2
6 29874335 S-1 monotherapy as second line chemotherapy in advanced gastric cancer patients previously treated with cisplatin/infusional fluorouracil [Retraction]. 2016 1
7 25550589 Phase I study of S-1 plus fractional cisplatin as adjuvant chemotherapy for advanced gastric cancer in an outpatient setting (KOGC-03). 2015 Jan 1
8 25707610 Clinical Benefit and Health-Related Quality of Life Assessment in Patients Treated with Cisplatin/S-1 Versus Cisplatin/5-FU: Secondary End Point Results From the First-Line Advanced Gastric Cancer Study (FLAGS). 2015 Jun 1
9 25933246 S-1 combined with cisplatin versus cisplatin alone for the treatment of advanced gastric cancer: a pilot randomized-controlled trial. 2015 Aug 1
10 24090674 Phase II study of S-1 monotherapy in patients over 75 years of age with advanced gastric cancer (OGSG0404). 2014 Feb 1
11 25031751 S-1 monotherapy as second line chemotherapy in advanced gastric cancer patients previously treated with cisplatin/infusional fluorouracil. 2014 3
12 25109221 Efficacy of S-1 in non-small cell lung cancer. 2014 Sep 1
13 25120809 S-1 monotherapy as second line chemotherapy in advanced gastric cancer patients previously treated with cisplatin/infusional fluorouracil. 2014 3
14 23507605 [A case of a septic pulmonary embolism-related implanted central venous port]. 2013 Mar 1
15 23868010 Feasibility trial for adjuvant chemotherapy with docetaxel plus cisplatin followed by single agent long-term administration of S-1 chemotherapy in patients with completely resected non-small cell lung cancer: Thoracic Oncology Research Group Study 0809. 2013 Aug 6 1
16 23975509 A phase II study of cisplatin /S-1 in patients with carcinomas of unknown primary site. 2013 Dec 1
17 24394072 [A case of gastric cancer accompanied by disseminated carcinomatosis of the bone marrow successfully controlled by S-1 and cisplatin combination therapy]. 2013 Nov 1
18 22584338 [A case of disseminated carcinomatosis of bone marrow treated by S-1 and cisplatin after distal gastrectomy for early gastric cancer]. 2012 May 2
19 22860709 S-1 for the treatment of gastrointestinal cancer. 2012 Sep 1
20 20809123 Feasibility study of adjuvant chemotherapy with S-1 plus cisplatin for gastric cancer. 2011 Jun 3
21 21364592 CYP2A6 and ERCC1 polymorphisms correlate with efficacy of S-1 plus cisplatin in metastatic gastric cancer patients. 2011 Mar 29 1
22 21677485 Efficacy and toxicity of S-1 plus cisplatin combination neoadjuvant chemotherapy in patients with oral cancer. 2011 Jun 1
23 22162925 Tegafur/gimeracil/oteracil (S-1) approved for the treatment of advanced gastric cancer in adults when given in combination with cisplatin: a review comparing it with other fluoropyrimidine-based therapies. 2011 1
24 20154479 [Combination therapy of S-1 and 24-h infusion of cisplatin after palliative gastrectomy for stage IV gastric cancer]. 2010 Feb 1
25 20629834 Metastatic cutaneous squamous cell carcinoma treated successfully with surgery, radiotherapy and S-1/cisplatin chemotherapy. 2010 Jul 1
26 20647727 [S-1-based chemotherapy for recurrent gastric cancer with peritoneal dissemination resulting in long-term survival--report of a case]. 2010 Jul 1
27 20820990 A feasibility study of postoperative chemotherapy with S-1 and cisplatin (CDDP) for gastric carcinoma (CCOG0703). 2010 Aug 2
28 21224577 [A case of liver metastasis of pancreatic cancer that was resistant to S-1 and gemcitabine successfully treated by 5-FU and cisplatin hepatic arterial infusion]. 2010 Nov 3
29 21430401 Phase II trial of S-1 plus low-dose cisplatin for unresectable and recurrent gastric cancer (JFMC27-9902 Step2). 2010 1
30 19056143 A phase I study of combination S-1 plus cisplatin chemotherapy with concurrent thoracic radiation for locally advanced non-small cell lung cancer. 2009 Jul 1
31 18195541 [A case of gastric cancer with multiple bone metastasis that responded to S-1 with low-dose cis-platinum]. 2008 Jan 2
32 18282805 S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial. 2008 Mar 1
33 18505092 Combination chemotherapy of S-1 and low-dose twice-weekly cisplatin for advanced and recurrent gastric cancer in an outpatient setting: a retrospective study. 2008 Mar-Apr 1
34 18751421 Phase 2 trial of oral S-1 combined with low-dose cisplatin for unresectable advanced pancreatic cancer. 2008 Jul-Aug 1
35 19343150 Advanced gastric cancer: an update and future directions. 2008 Jul 4
36 17673469 Relationship between expression of vascular endothelial growth factor in tumor tissue from gastric cancers and chemotherapy effects: comparison between S-1 alone and the combination of S-1 plus CDDP. 2007 Jul 1
37 17687213 [A case of curatively resected AFP producing gastric cancer with massive lymph node metastasis effectively treated by neoadjuvant-chemotherapy of S-1 and CDDP]. 2007 Aug 1
38 17699106 (Dihydro)ceramide synthase 1 regulated sensitivity to cisplatin is associated with the activation of p38 mitogen-activated protein kinase and is abrogated by sphingosine kinase 1. 2007 Aug 1
39 17701005 Treatment with an oral fluoropyrimidine, S-1, plus cisplatin in patients who failed postoperative gemcitabine treatment for pancreatic cancer: a pilot study. 2007 Aug 2
40 17906439 Medical treatment for advanced gastroesophageal adenocarcinoma. 2007 Nov 1
41 16619577 Feasibility study of biweekly CPT-11 plus CDDP for S-1- and paclitaxel-refractory, metastatic gastric cancer. 2006 Mar-Apr 2
42 16767371 Longterm survival of a Western patient with metastatic gastric cancer treated with S-1 plus cisplatin. 2006 1
43 16897973 [Clinical development of S-1 (TS-1) for advanced gastric cancer]. 2006 Jun 1
44 16898001 [Combination chemotherapy with S-1 and cisplatin for non-small cell lung cancer]. 2006 Jun 1
45 16953072 A case of early relapsed multiple lung metastases after esophagectomy successfully treated with S-1/cisplatin therapy after docetaxel/5-fluorouracil/cisplatin therapy. 2006 Aug 1
46 15757419 Available options in chemotherapy for advanced gastric cancer: the current developments in Japan. 2005 Feb 1
47 15864718 Long-term outcome of S-1 and cisplatin combination therapy in patients with advanced or recurrent gastric cancer. 2005 1
48 15886300 Sphingosine-1-phosphate lyase regulates sensitivity of human cells to select chemotherapy drugs in a p38-dependent manner. 2005 May 2
49 15014017 Combination phase I trial of a novel oral fluorouracil derivative S-1 with low-dose cisplatin for unresectable and recurrent gastric cancer (JFMC27-9902). 2004 Mar 1 1
50 15075664 The modulated oral fluoropyrimidine prodrug S-1, and its use in gastrointestinal cancer and other solid tumors. 2004 Feb 1